Elsewhere, a comparison of tau extracted from the human brain diagnosed with AD with a normal brain shows upregulated levels of GSK-3β with elevated tau phosphorylation in the brain of the former, suggesting GSK-3β has a principal role in the pathophysiology of AD (Medina et al., 2011). Here, MAPT is linked to Alzheimer disease.